Issues
- Current Issue
- Special Issues
Viewpoints
Education
Spotlight
News
Topic Compilations
On Location
Multimedia
- Sound Bites
- Meeting Coverage

Search

ASH Home
About ASH Clinical News
Authors
Advertising
Subscribe
Contact Us
eNewsletters

Cookie Settings

LOG IN

Welcome! Log into your account

Forgot your password?

Recover your password

ASH Clinical News

Issues
- All Current Issue Special Issues
  
  September 2021 Volume 7 Issue 11
  
  August 2021 Volume 7 Issue 10
  
  July 2021 Bonus Mid-Year Edition, Volume 7 Issue 9
  
  July 2021 Volume 7 Issue 8
Viewpoints
Education
Spotlight
News
Topic Compilations
On Location
Multimedia
- Sound Bites
- Meeting Coverage

Generic selectors

Exact matches only

Exact matches only

Search in title

Search in title

Search in content

Search in content

Search in excerpt

Search in posts

Search in posts

Search in pages

Search in pages

Alison R. Walker, MD, MPH, MBA

Alison R. Walker, MD, MPH, MBA

Associate Professor in the Division of Hematology, The Ohio State University

Advertisement

Current Issue

September 2021 Volume 7 Issue 11

Wednesday, September 1, 2021

This issue discusses fertility preservation for young patients with cancer, reviews treatment options for primary immune thrombocytopenia, and more.

Block title

Zanubrutinib Approved for Waldenström Macroglobulinemia

Sunday, September 12, 2021

Two Decades After 9/11, Cancer and Other Chronic Conditions Linger

Sunday, September 12, 2021

FDA Grants Orphan Drug Designation to Gavo-Cel for Cholangiocarcinoma

Sunday, September 12, 2021

Organizations Comment on the FDA’s Draft Guidance Expanding Clinical Trial Eligibility

Wednesday, September 8, 2021

Democrats Consider Plan to Cover Uninsured in Non-Medicaid Expansion States

Wednesday, September 8, 2021

Recent Posts

Zanubrutinib Approved for Waldenström Macroglobulinemia
Two Decades After 9/11, Cancer and Other Chronic Conditions Linger
FDA Grants Orphan Drug Designation to Gavo-Cel for Cholangiocarcinoma
Organizations Comment on the FDA’s Draft Guidance Expanding Clinical Trial Eligibility

Meeting Coverage

Researchers Validate Burkitt Lymphoma Prognostic Index

Monday, March 1, 2021

Thiotepa-Containing Conditioning Regimens Improve Survival Outcomes in Patients With PCNSL

Monday, March 1, 2021

Editor's Corner

Editor’s Corner: Chance Encounters of the Third Kind

Wednesday, September 1, 2021

Sex Cells: The Forgotten Biological Variable

Sunday, August 1, 2021

2021 L Street NW, Suite 900, Washington, DC 20036
Phone 202-776-0544 | Fax 202-776-0545

ASH Home
Research
Education
Advocacy
Meetings
Publications
ASH Store

Copyright © 2020 by American Society of Hematology

Contact Us | Terms of Service | Privacy Policy